National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018

Similar documents
Copenhagen, Denmark, September August Malaria

Dental Practitioner Programs Currently Accredited by the ADC

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated)

Dental Practitioner Programs Currently Accredited by the ADC

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

EC research and innovation strategy and actions

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Understanding vaccine development

The WHO END-TB Strategy

The EU strategy in Horizon2020 to fight poverty related diseases

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

SAMRC S RESPONSE TO HIV & TB: WALKING THE TALK: MOVING TO CONTROL

Overall presentation of IVR Strategy

Dental Practitioner Programs Currently Accredited by the ADC

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director

EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

Horizon Introduction. Alex Harris Medical Research Council

The Burden of TB in the Population under the Partnership in Health Project

the Office of Research Application Portal: Materials to submit:

Intervention thematic group strategic portfolio

Letter from the CEO. Dear Friends of IAVI,

Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women

1 introduction strengthening and ac- celerating future vaccine innovation and development for diseases of poverty.

DTA3/COFUND Programme Research Project Proforma

JOINING FORCES COLLABORATING WITH PARTNERS Annual Report

The Western Pacific Region faces significant

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

NIAID GL OBAL HEAL TH RESEAR CH PL AN FOR HIV/AIDS, MAL ARIA, AND TUBER CUL OSIS

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

Malaria Vaccine Pipeline

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

The Global Fund & UNICEF Partnership

GUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS

Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Finding the missing TB cases

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Product Development for Vaccines Advisory Committee:

TB Vaccine Development Strategy Overview

Version for the Silent Procedure 29 April Agenda item January Hepatitis

DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI

Rural and remote health care research funding at NHMRC opportunities and barriers

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6

Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network:

Updating the Malaria Vaccine Technology Roadmap

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

Gesundheit in Horizont 2020

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

The Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong

IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting

Dentist labour force projections,

Update on TB Vaccines

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

High Level Across Sector Support to Implement the Three Plans South Australian Aboriginal Chronic Disease Consortium Goal Vision

Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Malaria Information & Prevention

Our T cell epitope test service offers you:

Innovation, Access and Delivery for Universal Health Coverage

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

Children s Cancer Institute Strategic Plan It s not if. It s when. STRATEGIC PLAN

HIV/AIDS in East Asia

7. Are you currently engaged in research that could support new TB diagnostic assay development? Yes No

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014

Stakeholders meeting on Malaria

Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT)

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

World Health Organization. A Sustainable Health Sector

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation

Identification of vaccine candidate antigens for a Babesia bovis transmission blocking vaccine

Kato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1

Policy Document. Tobacco Free Campuses Policy. Background

Global progress in vaccine development

Dr Graeme Suthers: The genetic basis of cancer

Translating Duke Health. Accelerating discovery and its translation

Human Health Using nuclear techniques to improve health around the world

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework

Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System

award M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens Mireia Coscolla

Global dengue situation and strategy for prevention and control ALERT AND RESPONSE OPERATIONS

Consultation on proposed changes to prescribed qualifications

Epidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM

ACCEPTED. Diseases, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia

Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

Childhood Vaccination and Immunisation

FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY PROCEEDINGS. 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION

Communicable Disease Control And Health Protection Handbook Third Edition

Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012,

A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT. Introducing the Gates Medical Research Institute

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia

Transcription:

National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018 The NHMRC has publically released results (embargo lifted on 11 October 2017) for the Early Career Fellowships, Practitioner Fellowships, Research Fellowships and Australia/European Union Collaborative Research Grants Scheme for funding in 2018. For this round, across the sector: 472 applications were submitted to the Early Career Fellowships Scheme. 120 were funded with a success rate of 25.4% and total funding of $38,526,110 was awarded. 388 applications were submitted to the Career Development Fellowships scheme. 61 were funded with a success rate of 15.7% and total funding of $26,660,345. 322 applications were submitted to the Research Fellowships Scheme. 76 were funded with a success rate of 23.6% and total funding of $57,738,355 was awarded. 71 applications were submitted to the Practitioner Fellowships Scheme. 16 were funded with a success rate of 22.5% % and total funding of $7,724,511 was awarded 4 applications were submitted to the Australia/European Union Collaborative Research Grant Scheme. 4 were. awarded with total funding of $1,902,628 For this round, James Cook University: 1 5 Early Fellowships. 1 was awarded at $317,768 over 4 years 4 Career Development Fellowships. 2 were awarded at $862,000 over 4 years 4 Research Fellowships. 1 was awarded at $849,540 over 5 years No Practitioner Fellowships were submitted in this round 1 Australia/European Union Collaborative Research Grant Scheme. 1 was awarded at $488,914 over 2 years TOTAL FUNDS AWARDED TO JCU $2,518,222

Details of successful James Cook University fellowships: Early Career Fellowships Scheme App Id Chief Investigator Title $ 1139756 Dr Matt Developing Core Bioinformatics $318,768 Field Capacity at AITHM Dr Matt Field Developing Core Bioinformatics Capacity at AITHM $318,768 over 4 years Cost effective next generation sequencing is now a reality, meaning the bottleneck for research projects has shifted from data generation to data analysis. Researchers at the Australian Institute of Health and Tropical Medicine (AITHM) are engaged in an increasing number of high-impact research projects that require timely access to high-throughput bioinformatics best-practices methodologies. This proposal outlines strategies to develop support for projects requiring bioinformatics within AITHM. Career Development Fellowships 1140709 Dr Andreas New strategies for improved TB $431,000 Kupz vaccines Dr Andreas Kupz New strategies for improved TB vaccines $431,000 over 4 years Tuberculosis is a major global public health problem and continues to cause significant morbidity and mortality due to the low efficiency of the only licensed anti-tuberculosis vaccine, BCG. This project aims to produce novel, highly efficacious vaccination regimens against tuberculosis, especially pulmonary tuberculosis, which is currently the most difficult manifestation of infection to control. The results of this project have the potential to not only save millions of lives in the developing world but also to decrease socioeconomic burden of tuberculosis, particularly in the context of HIV coinfection. 1141441 Prof Stephan Karl Unravelling Plasmodium vivax transmission to mosquitoes $431,000 Professor Stephan Karl Unravelling Plasmodium vivax transmission to mosquitoes $431,000 over 4 years This project is aimed at better understanding transmission of P. vivax, the world s most widely spread malaria parasite. Using a newly established experimental platform that enables us to feed P. vivax infected blood to Anopheles farauti mosquitoes, we can start researching factors in human blood that determine P. vivax infection success, test new vaccine and drug candidates for their ability to block transmission and thus significantly advance science surrounding this neglected parasite. 2 Research Fellowships 1137285 Prof Denise Doolan System-based approaches to inform the design of immunotherapies and immunodiagnostics against chronic pathogens $849,540 Professor Denise Doolan System-based approaches to inform the design of immunotherapies and immunodiagnostics against chronic pathogens $849,540 over 5 years

The development of effective interventions against malaria and other chronic infectious diseases is impeded by a lack of understanding of host-pathogen interactions and the mechanisms and antigenic targets underlying protective immunity. The fundamental premise of this proposal is that integrated and unbiased systems-level approaches provide an excellent framework to develop a comprehensive understanding of immune responses and identify key molecules/pathways that can be targeted for therapeutic intervention or for immunodiagnostics. Taking advantage of unique human experimental infection models and field studies, this research encompasses: (i) antigen discovery; (ii) hostpathogen immunity; (iii) vaccine engineering; and (iv) biomarker discovery. It will develop a pipeline of parasite antigens and immunomodulatory molecules that can be transitioned towards clinical development and testing, as well as identify biomarkers of disease risk that can be used for population based screening to define at-risk individuals for targeted intervention. Practitioner Fellowships Nil Australia/European Union Collaborative Research Grant Prof Denise Doolan OptiMalVax: Optimising a deployable high efficacy malaria vaccine $488,914 Professor Denise Doolan OptiMalVax: Optimising a deployable high efficacy malaria vaccine $488,914 over 2 years This project takes advantage of new vaccine technologies and antigen discovery approaches for accelerated design and development of a highly effective multi-antigen multi-stage subunit vaccine against malaria. A consortium comprising key malariologists, vaccine researchers and product developers in Europe, USA, Australia and Africa are collaborating in an innovative programme of antigen discovery science linked to rapid clinical development of new vaccine candidates. The workplan directly addresses tough problems in malaria vaccine design such as antigen choice and polymorphism as well as vaccine immunogenicity, efficacy, and durability, and employs stringent infectious challenges and functional assays to ensure biologically relevant outcomes. 3

Analysis of JCU activity over last rounds: Early Career Fellowships 2017 2016 2015 2014 2013 5 3 1 5 5 1 1 0 1 2 Amount$ $318,768 $318,768 0 $309,436 $609,192 JCU % 20.0% 33% 0 20% 40% NHMRC % 25.4% 24.1% 21.4% 22.4% 24.5% Career Development Fellowships 2017 2016 2015 2014 2013 4 1 1 0 0 2 1 0 0 0 Amount$ $862,000 $569,219 0 0 0 JCU % 50% 100% 0 0 0 % 15.7% 13.3% 29.4% 29.8% 28.1% Research Fellowships 2017 2016 2015 2014 2013 4 4 2 0 0 1 1 0 0 0 Amount$ $849,540 $938,910 0 0 0 JCU % 25% 25% 0 0 0 NHMRC % 23.6% 26.1% 24.1% 30.1% 32.4% 4 Practitioner Fellowships 2017 2016 2015 2014 2013 0 1 1 0 0 0 1 0 0 0 Amount$ 0 $569,219 0 0 0 JCU % 0 100% 0 0 0 NHMRC % 0 30.9% 29.4% 29.8% 28.1%

Aust/European Union 1 Amount$ $488,914 JCU % 100% NHMRC % 2017 2017 First Call for the scheme 1 100% 5

s Comparisons for IRU and Go8 for this round (2017 Fellowships): EARLY CAREER FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University 5 1 20.0% $318,768 Charles Darwin University 0 0 0 0 Flinders University 6 0 0 0 Griffith University 8 2 25.0% $637,536 La Trobe University 10 5 50.0% $1,552,579 Murdoch University 2 1 50.0% $318,768 Western Sydney University 0 0 0 0 Group of Eight (Go8) Go8 University of Adelaide 27 11 40.7% $3,812,448 Australian National University 9 0 0 0 University of Melbourne 49 13 26.5% $4,000,694 Monash University 54 17 31.5% $5,215,766 University of New South Wales 34 15 44.1% $4,816,382 University of Queensland 34 10 29.4% $3,118,296 University of Sydney 55 14 25.5% $4,290,600 University of Western Australia 16 5 31.3% $1,606,210 6

CAREER DEVELOPMENT FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University 4 2 50% $862,000 Charles Darwin University 0 0 0 0 Flinders University 2 0 0 0 Griffith University 5 0 0 0 La Trobe University 4 0 0 0 Murdoch University 0 0 0 0 Western Sydney University 0 0 0 0 Group of Eight (Go8) Go8 University of Adelaide 16 1 6.3% $431,000 Australian National University 6 1 16.7% $476,728 University of Melbourne 53 12 22.6% $5,303,350 Monash University 27 6 22.2% $2,723,184 University of New South Wales 42 11 26.2% $5,061,096 University of Queensland 36 3 8.3% $1,338,728 University of Sydney 35 7 20.0% $2,741,475 University of Western Australia 18 1 5.6% $431,000 7

RESEARCH FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University 4 1 25.0% $849,540 Charles Darwin University 0 0 0 0 Flinders University 2 0 0 0 Griffith University 6 2 33.3% $1,556,910 La Trobe University 5 1 20.0% $782,370 Murdoch University 0 0 0 0 Western Sydney University 1 0 0 0 Group of Eight (Go8) Go8 University of Adelaide 17 0 0 0 Australian National University 6 3 50.0% $2,197,120 University of Melbourne 31 12 38.7% $8,983,580 Monash University 50 11 22.0% $8,141,880 University of New South Wales 14 4 28.6% $3,274,625 University of Queensland 23 7 30.4% $4,985,915 University of Sydney 28 7 25.0% $5,682,505 University of Western Australia 4 2 50.0% $1,280,420 8

PRACTITIONER FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University 0 0 0 0 Charles Darwin University 0 0 0 0 Flinders University 0 0 0 0 Griffith University 1 0 0 0 La Trobe University 1 0 0 0 Murdoch University 0 0 0 0 Group of Eight (Go8) Go8 University of Adelaide 1 1 100% $577,189 Australian National University 0 0 0 0 University of Melbourne 11 2 18.2% $1,058,344 Monash University 11 2 18.2% $975,889 University of New South Wales 3 0 0 0 University of Queensland 5 0 0 0 University of Sydney 10 5 50% $2,322,898 University of Western Australia 8 1 12.5% $577,189 9